HistoWiz

About:

HistoWiz provides automated histopathology for biomedical researchers.

Twitter/X: HistoWiz

Top Investors: Y Combinator, Vivo Capital, Evan Cheng, Asahi Kasei, venBio Partners

Description:

HistoWiz is a biotech company that automates the processing and digitizing of tissue samples for pharma and academia. Through its fully automated histology lab and the world’s first online pathologist network, HistoWiz processes and annotates tissue samples which are stored on PathologyMap, its cloud database, as a resource for cancer researchers. The data stored on PathologyMap enables the integration of technology and the development of AI tools for digital pathology on an unprecedented scale.

Total Funding Amount:

$36.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)histowiz.com

Founders:

Ke Cheng

Number of Employees:

11-50

Last Funding Date:

2021-10-19

IPO Status:

Private

Industries: